Datos finales de la Fase II que evalan REVLIMID y rituximab en pacientes con leucemia linfoctica crnica recurrente o resistente

Show Health and Fitness Publications

Tue, December 20, 2011

[ Tue, Dec 20th 2011 ]: Market Wire

Ergoresearch LTD Annonces its Best First Quarter Ever

[ Tue, Dec 20th 2011 ]: Market Wire

Isis Pharmaceuticals Announces Its R&D Webcast Presentation

[ Tue, Dec 20th 2011 ]: Market Wire

Compugen to Broaden and Accelerate Monoclonal Antibody Program for Oncology and Immunology

[ Tue, Dec 20th 2011 ]: Market Wire

Imaging Diagnostic Sells Its CTLM System to China

[ Tue, Dec 20th 2011 ]: Market Wire

Covidien kondigt CE-markering aan voor Nellcora" Respiration Rate Software

[ Tue, Dec 20th 2011 ]: Market Wire

Allezoe Medical Holdings (ALZM) Completes Exclusive Licensing Deal for HPV Diagnostic Technology

[ Tue, Dec 20th 2011 ]: Market Wire

Dynavax Initiates Proof of Mechanism Trial in Lupus Patients

[ Tue, Dec 20th 2011 ]: Market Wire

Improved Treatments for Brain Cancers Highlighted .. at Annual Society of Neuro-Oncology (SNO) Meeting

[ Tue, Dec 20th 2011 ]: Market Wire

Repligen Completes Acquisition of Novozymes Biopharma Sweden AB

[ Tue, Dec 20th 2011 ]: Market Wire

Prestige Brands Holdings, Inc. Signs Definitive A .. 17 Consumer OTC Healthcare Brands in North Ameri

[ Tue, Dec 20th 2011 ]: Market Wire

Oncothyreon Files Investigational New Drug Application for ONT-10

[ Tue, Dec 20th 2011 ]: Market Wire

Equity Research on Universal Health Services Inc. .. Inc. - Healthcare Hospitals Acquiring Facilities

[ Tue, Dec 20th 2011 ]: Market Wire

Pfizer Announces FDA Acceptance For Review Of New .. inib For Adult Patients With Moderately To Severe

[ Tue, Dec 20th 2011 ]: Market Wire

Covidien anuncia obtencin de la marca CE para su software de frecuencia respiratoria Nellcora"

[ Tue, Dec 20th 2011 ]: Market Wire

Molinaas Medicaid Claims Processing System Receives Full Federal Certification in Maine

[ Tue, Dec 20th 2011 ]: Market Wire

Mylan Receives WHO Approval for Innovative 'Second-Line-in-a-Box' HIV/AIDS Treatment

[ Tue, Dec 20th 2011 ]: Market Wire

Warnex to Sell Its Analytical Services Division

[ Tue, Dec 20th 2011 ]: Market Wire

Implant Sciences' Quantum Sniffer QS-B220 Receive .. for TSA Air Cargo Screening Qualification Testin

[ Tue, Dec 20th 2011 ]: Market Wire

Salix and Progenics Announce Positive Highly Stat .. of Oral Methylnaltrexone for Phase 3 Trial in Ch

[ Tue, Dec 20th 2011 ]: Market Wire

Covidien annuncia marchio CE per software Nellcora" Respiration Rate

[ Tue, Dec 20th 2011 ]: Market Wire

Agenus and NewVac Enter Into Agreement in the Area of Personalized Cancer Vaccines

[ Tue, Dec 20th 2011 ]: Market Wire

Covidien annonce le marquage CE de son logiciel N .. cora" de surveillance de la frquence respiratoire

[ Tue, Dec 20th 2011 ]: Market Wire

Covidien meldet CE-Kennzeichnung fr Nellcora" Respiration Rate Software

Mon, December 19, 2011

[ Mon, Dec 19th 2011 ]: Market Wire

TPI Attends 30th J.P. Morgan Healthcare Conference at San Francisco

[ Mon, Dec 19th 2011 ]: Market Wire

Life Technologies to Present at Upcoming Investment Conferences in January

[ Mon, Dec 19th 2011 ]: Market Wire

The Law Firm of Levi & Korsinsky, LLP Launches an .. Securities Laws Violations by Invacare Corporatio

[ Mon, Dec 19th 2011 ]: Market Wire

Bronstein, Gewirtz & Grossman, LLC Announces Investigation into Invacare Corporation

[ Mon, Dec 19th 2011 ]: Market Wire

Imaging Diagnostic Systems Assigns ID-Matrix Systems as Exclusive Distributor for China

[ Mon, Dec 19th 2011 ]: Market Wire

Southern California Investment Forum Hosts an Inv .. hering Today at the Pacific Club in Newport Beach

[ Mon, Dec 19th 2011 ]: Market Wire

BioElectronics Announces Chinese Patent

[ Mon, Dec 19th 2011 ]: Market Wire

Unigene's 2011 Year in Review - Key Elements in Place to Address Debt in 2012

[ Mon, Dec 19th 2011 ]: Market Wire

Zimmer Initiates Quarterly Dividend and Announces New Share Repurchase Program

[ Mon, Dec 19th 2011 ]: Market Wire

Kindred Healthcare Promotes Patricia M. Henry to President of RehabCare Division

[ Mon, Dec 19th 2011 ]: Market Wire

Vermillion Completes the Acquisition of Correlogic Systems' Ovarian Cancer Diagnostics Business

[ Mon, Dec 19th 2011 ]: Market Wire

Cytori Completes IDE Filing for Chronic Myocardial Ischemia ATHENA Trial of the Celution(R) System

[ Mon, Dec 19th 2011 ]: Market Wire

Valeant Pharmaceuticals Completes Acquisition of Dermik

[ Mon, Dec 19th 2011 ]: Market Wire

Ardea Biosciences Initiates Phase 3 Clinical Development Program for Lesinurad

[ Mon, Dec 19th 2011 ]: Market Wire

Galectin Therapeutics Provides Corporate Update

[ Mon, Dec 19th 2011 ]: Market Wire

Somaxon Pharmaceuticals Hires Financial Advisor to Assist in Seeking Strategic Alternatives

[ Mon, Dec 19th 2011 ]: Market Wire

Isis Initiates Phase 1 Clinical Study of ISIS-SMNRx in Patients With Spinal Muscular Atrophy

[ Mon, Dec 19th 2011 ]: Market Wire

Equity Research on St. Jude Medical Inc. and Medt .. nt Cutbacks Affecting Medical Appliances &;

[ Mon, Dec 19th 2011 ]: Market Wire

Leading U.S. Healthcare Providers Ordering Sequenom Center for Molecular Medicine's MaterniT21 LDT

[ Mon, Dec 19th 2011 ]: Market Wire

Pharmacyclics Inc. Receives Issue Notice of Significant Bruton's Tyrosine Kinase (BTK) Patent

[ Mon, Dec 19th 2011 ]: Market Wire

PDL BioPharma Provides Fourth Quarter 2011 Revenue Guidance of $72 Million

[ Mon, Dec 19th 2011 ]: Market Wire

Pacira Pharmaceuticals, Inc. Announces Results fr .. Trial Published in Diseases of the Colon & Rectum

[ Mon, Dec 19th 2011 ]: Market Wire

DDC, One of the Largest DNA Testing Companies Wor .. the Acquisition of Orchid Cellmark's Government P

[ Mon, Dec 19th 2011 ]: Market Wire

Perceptive Informatics DataLabs EDC Solution Impl .. 15 of the Top Global Biopharmaceutical Companies

Sun, December 18, 2011

[ Sun, Dec 18th 2011 ]: Market Wire

Galapagos achieves clinical Proof-of-Mechanism milestone in GSK alliance

Sat, December 17, 2011

[ Sat, Dec 17th 2011 ]: Market Wire

Bull & Lifshitz, LLP Announces Investigation of Synovis Life Technologies, Inc.

Fri, December 16, 2011

[ Fri, Dec 16th 2011 ]: Market Wire

HealthSouth to Present at the 30th Annual J.P. Morgan Healthcare Conference

[ Fri, Dec 16th 2011 ]: Market Wire

Mylan Launches Generic Version of Toprol-XL Tablets

[ Fri, Dec 16th 2011 ]: Market Wire

Herbalife statement regarding Belgian Commercial Court Ruling

[ Fri, Dec 16th 2011 ]: Market Wire

St. Jude Medical meldt eerste implantatie in Euro .. ch onderzoek naar Portico transcatheter aortaklep

[ Fri, Dec 16th 2011 ]: Market Wire

Genomsequenzierung frdert Forschung auf dem Gebie .. weit verbreiteten Volkskrankheiten in Frankreich.

[ Fri, Dec 16th 2011 ]: Market Wire

Humana Military Makes the Holidays Brighter for Children

[ Fri, Dec 16th 2011 ]: Market Wire

ARIAD Announces Underwritersa Exercise of Over-Allotment Option

[ Fri, Dec 16th 2011 ]: Market Wire

Dehaier Medical Enters European Homecare Medical Product Market

[ Fri, Dec 16th 2011 ]: Market Wire

Landmark Publication Endorses Prana's Drug Pipeli .. Strategy for Treating Neurodegenerative Diseases

[ Fri, Dec 16th 2011 ]: Market Wire

Ariad, Delta Air Lines, BioSante, Bank of America, Boston Scientific and News Corp

[ Fri, Dec 16th 2011 ]: Market Wire

Catasys Adds Another Customer in Massachusetts

[ Fri, Dec 16th 2011 ]: Market Wire

AtriCureas Synergy Ablation System Receives FDA Approval for the Treatment of Atrial Fibrillation

[ Fri, Dec 16th 2011 ]: Market Wire

Underperforming Medtronic and Allezoe Medical Look to Turn Around Fortunes in 2012

[ Fri, Dec 16th 2011 ]: Market Wire

Recent FDA Approvals for Antares Pharma and Boston Scientific Have Done Little to Boost Shares

[ Fri, Dec 16th 2011 ]: Market Wire

China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise

[ Fri, Dec 16th 2011 ]: Market Wire

Trimel to Present Anorgasmia (FSD) Phase II Clinical Trial Results

[ Fri, Dec 16th 2011 ]: Market Wire

Valeant Pharmaceuticals Proposes to Acquire ISTA Pharmaceuticals Inc. for $6.50 Per Share in Cash

[ Fri, Dec 16th 2011 ]: Market Wire

Kensey Nash to Enter Into Mediation with St. Jude Medical over Angio-Seal Contract Disputes

[ Fri, Dec 16th 2011 ]: Market Wire

Pfizer Broadens and Extends Commitment to Help Pr .. Infants and Young Children in the Worldas Poores

[ Fri, Dec 16th 2011 ]: Market Wire

Thoratec Announces Appointment of William A. Hawkins to Board of Directors

[ Fri, Dec 16th 2011 ]: Market Wire

Valeant Announces Successful Results From Phase III Onychomycosis Trials

[ Fri, Dec 16th 2011 ]: Market Wire

La secuenciacin del genoma ayuda a la investigacin de las enfermedades pblicas en Francia

[ Fri, Dec 16th 2011 ]: Market Wire

Concord Medical to Present at the 30th Annual J.P. Morgan Healthcare Conference in January 2012

[ Fri, Dec 16th 2011 ]: Market Wire

Centene Corporation Announces 2012 Financial Guidance

Thu, December 15, 2011

[ Thu, Dec 15th 2011 ]: Market Wire

Die US-Arzneimittelbehrde FDA hat einem beschleun .. KALYDECOa" (Ivacaftor) zugestimmt, das erste pote

[ Thu, Dec 15th 2011 ]: Market Wire

Pomerantz Law Firm Investigates Claims on Behalf of Investors of SonoSite, Inc.

[ Thu, Dec 15th 2011 ]: Market Wire

The Law Firm of Levi &;; Korsinsky, LLP .. of Breaches of Fiduciary Duty by the Board of Sy

[ Thu, Dec 15th 2011 ]: Market Wire

Rigrodsky & Long, P.A. Announces Investigation of .. ite, Inc.as Sale to Fujifilm Holdings Corporation

[ Thu, Dec 15th 2011 ]: Market Wire

St. Jude gibt erste Implantation der Transkathete .. ahmen einer europischen klinischen Studie bekannt

[ Thu, Dec 15th 2011 ]: Market Wire

Orexigen Therapeutics Prices Public Offering of Common Stock and Warrants to Purchase Common Stock

[ Thu, Dec 15th 2011 ]: Market Wire

Critical Stock Alerts for Eli Lilly, NVIDIA, Inte .. mana Gold, Charles Schwab, and MF Global Holdings

[ Thu, Dec 15th 2011 ]: Market Wire

Vista Partners Updates Coverage on ADVENTRX Pharmaceuticals, Inc.;; $3.50 Target Price

[ Thu, Dec 15th 2011 ]: Market Wire

TheraBiogen Announces National Cable Television Ad Campaign Launches YouTube Page

[ Thu, Dec 15th 2011 ]: Market Wire

p-Value Capital Management, LLC Comments on Results of Myrexis, Inc. Shareholder Vote

[ Thu, Dec 15th 2011 ]: Market Wire

Graymark Healthcare Closes Acquisition of Village Sleep Center in Plano, Texas

[ Thu, Dec 15th 2011 ]: Market Wire

New Management Changes Poise USANA for Further Growth

[ Thu, Dec 15th 2011 ]: Market Wire

Covidien meldt conference call en webcast

[ Thu, Dec 15th 2011 ]: Market Wire

Gruppo di ricerca per il linfoma negli adulti (GE .. LIMID per studio sul secondo tipo di linfoma pi c

[ Thu, Dec 15th 2011 ]: Market Wire

Covidien annuncia una teleconferenza e trasmissione web

[ Thu, Dec 15th 2011 ]: Market Wire

Arrowhead to Report Fiscal 2011 Fourth Quarter and Year-End Financial Results

[ Thu, Dec 15th 2011 ]: Market Wire

Covidien plant Ausgliederung des Unternehmensbereichs Pharmazeutika

[ Thu, Dec 15th 2011 ]: Market Wire

Covidien envisage une scission de sa branche Pharmacie

[ Thu, Dec 15th 2011 ]: Market Wire

Soligenix Initiates Next Generation Anthrax Vacci .. t Program Under Agreement With Harvard University

[ Thu, Dec 15th 2011 ]: Market Wire

SciClone Pharmaceuticals Announces Final Settlement of Stockholder Derivative Litigation

[ Thu, Dec 15th 2011 ]: Market Wire

Implant Sciences Sells Over $200,000 of Quantum S .. s Trace Detectors for Building Security in Mexico

[ Thu, Dec 15th 2011 ]: Market Wire

Importante grupo cooperativo de investigacin sobr .. elige REVLIMID para el estudio del segundo subtip

[ Thu, Dec 15th 2011 ]: Market Wire

Perceptive Informatics Completes Over 500 System .. Industry Continues to Adopt Seamless eClinical S

[ Thu, Dec 15th 2011 ]: Market Wire

Illumina Hires Laura Lauman as Vice President of Marketing

Wed, December 14, 2011

[ Wed, Dec 14th 2011 ]: Market Wire

Isis Adds Three New Drugs to Its Development Pipeline

[ Wed, Dec 14th 2011 ]: Market Wire

AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance

[ Wed, Dec 14th 2011 ]: Market Wire

Anthera Announces Completion of Safety Review by DSMB for VISTA-16

[ Wed, Dec 14th 2011 ]: Market Wire

BioSante Pharmaceuticals Announces Results from LibiGel Efficacy Trials

[ Wed, Dec 14th 2011 ]: Market Wire

Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012

[ Wed, Dec 14th 2011 ]: Market Wire

ViroPharma Announces Approval of Modernized Label .. Vancocin (vancomycin hydrochloride, USP) Capsules

[ Wed, Dec 14th 2011 ]: Market Wire

Positron's Attrius Receives Health Canada Approval

[ Wed, Dec 14th 2011 ]: Market Wire

AIM Honored for Innovative Program That Helps Consumers Make Better Choices About Their Care

[ Wed, Dec 14th 2011 ]: Market Wire

Vooraanstaande samenwerkingsgroep voor lymfoomond .. ) kiest REVLIMID voor onderzoek naar tweede meest

[ Wed, Dec 14th 2011 ]: Market Wire

Amica Mature Lifestyles Announces Closing of Subs .. cluding Exercise in Full of Over-Allotment Option

[ Wed, Dec 14th 2011 ]: Market Wire

Amgen Announces Final Results of Its Tender Offer

[ Wed, Dec 14th 2011 ]: Market Wire

St. Jude Medical annuncia il primo impianto nella .. clinica per la valutazione dalla valvola cardiac

[ Wed, Dec 14th 2011 ]: Market Wire

CytoSorbents Awarded US Army SBIR Trauma Grant

[ Wed, Dec 14th 2011 ]: Market Wire

Definitieve fase 2 gegevens van evaluatie REVLIMI .. et recidiverende of refractaire chronische lymfat

[ Wed, Dec 14th 2011 ]: Market Wire

Datos finales de la Fase II que evalan REVLIMID y .. eucemia linfoctica crnica recurrente o resistente

[ Wed, Dec 14th 2011 ]: Market Wire

Premiere Cooperative Group in Adult Lymphoma Rese .. for Study in Second Most Common Lymphoma Subtype

[ Wed, Dec 14th 2011 ]: Market Wire

Salix Pharmaceuticals Announces NDA Submission fo .. emer for the Treatment of HIV-Associated Diarrhea

[ Wed, Dec 14th 2011 ]: Market Wire

Meta-analysis of Five Clinical Trials including C .. T Study Published in American Journal of Obstetri

[ Wed, Dec 14th 2011 ]: Market Wire

REVLIMID evaluado en combinacin con rituximab com .. pacientes con leucemia linfoctica crnica no trata

[ Wed, Dec 14th 2011 ]: Market Wire

Presentados en ASH los datos de un estudio de Fas .. en pacientes con mieloma indolente de alto riesgo

[ Wed, Dec 14th 2011 ]: Market Wire

OncoSec Medical Engages The Investor Relations Group

[ Wed, Dec 14th 2011 ]: Market Wire

Rsultats dfinitifs de laessai de phase II valuant .. ez les patients atteints de leucmie lymphocytaire

[ Wed, Dec 14th 2011 ]: Market Wire

Threshold Pharmaceuticals Announces Promising Pha .. Trial Results in Patients With Advanced Leukemias

[ Wed, Dec 14th 2011 ]: Market Wire

REVLIMID a t valu en combinaison avec le Rituxima .. ntiel destin aux patients atteints de leucmie lym

Tue, December 13, 2011

[ Tue, Dec 13th 2011 ]: Market Wire

Bio-Path Holdingsa Initial Phase I Data in Leukem .. s That Its Neutral Lipid Delivery Technology Anti

[ Tue, Dec 13th 2011 ]: Market Wire

Direction of Market Influences - Report Highlight .. ceutical Industries Ltd (ADR) and Sanofi SA (ADR)

[ Tue, Dec 13th 2011 ]: Market Wire

GenVec President and Chief Executive Officer Announces Retirement

[ Tue, Dec 13th 2011 ]: Market Wire

China Botanic Announces Development of New Siberian Ginseng Polysaccharide Extract Powder

[ Tue, Dec 13th 2011 ]: Market Wire

Fase 2-onderzoek evalueert klinisch profijt van p .. j eerder behandelde patinten met multipel myeloom

[ Tue, Dec 13th 2011 ]: Market Wire

Endgltige Daten aus multizentrischer Phase-II-Stu .. binationstherapie von VIDAZA und REVLIMID fr MDS-

[ Tue, Dec 13th 2011 ]: Market Wire

Nektar Announces Positive Clinical Data from Seco .. NKTR-181, a Novel Opioid Analgesic Molecule to Tr

[ Tue, Dec 13th 2011 ]: Market Wire

Stem Cell Therapeutics Announces Additions to Advisory Board

[ Tue, Dec 13th 2011 ]: Market Wire

Eindgegevens van Fase II multi-center onderzoek n .. REVLIMID bij patinten met hoogrisico MDS gepresen

[ Tue, Dec 13th 2011 ]: Market Wire

BioLineRx to Develop and Commercialize Novel Peptide Drug Candidates Discovered by Compugen

[ Tue, Dec 13th 2011 ]: Market Wire

Synergy Pharmaceuticals, Inc. reicht Klage ein ge .. Inc. und dessen Chief Scientific Officer und Sen

[ Tue, Dec 13th 2011 ]: Market Wire

Prsentation laASH des rsultats dfinitifs daune tu .. I valuant la combinaison de VIDAZA et de REVLIMID

[ Tue, Dec 13th 2011 ]: Market Wire

Une tude de phase III avec traitement continu de .. ion statistiquement considrable de la survie sans

[ Tue, Dec 13th 2011 ]: Market Wire

Phase-III-Studie mit kontinuierlicher REVLIMID-Th .. ifikante Verbesserung der progressionsfreien berl

[ Tue, Dec 13th 2011 ]: Market Wire

Threshold Pharmaceuticals Announces Update to TH- .. resented at the Oppenheimer Healthcare Conference

[ Tue, Dec 13th 2011 ]: Market Wire

NTRR Targets $390 Billion Weight Loss and Diet Management Market

[ Tue, Dec 13th 2011 ]: Market Wire

FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVEa"

[ Tue, Dec 13th 2011 ]: Market Wire

Radient Pharmaceuticals Launches New Onko-Sure Website, Facebook and Twitter Outreach

[ Tue, Dec 13th 2011 ]: Market Wire

Une tude de dosage value REVLIMID chez des patien .. aits, atteints de leucmie lymphocytaire chronique

[ Tue, Dec 13th 2011 ]: Market Wire

Les rsultats d'une analyse comparative rvlent que .. tistiquement significative le risque de dcs, sans

[ Tue, Dec 13th 2011 ]: Market Wire

Synergy Pharmaceuticals, Inc. dpose plainte contr .. Inc. et son conseiller scientifique en chef et VP

[ Tue, Dec 13th 2011 ]: Market Wire

Synergy Pharmaceuticals, Inc. Files Suit Against .. c. and its Chief Scientific Officer and Senior VP

[ Tue, Dec 13th 2011 ]: Market Wire

Synergy Pharmaceuticals, Inc. fa causa ad Ironwoo .. suo Direttore Scientifico e Vicepresidente Senior

[ Tue, Dec 13th 2011 ]: Market Wire

Synergy Pharmaceuticals, Inc. spant geding aan te .. , Inc. en haar Chief Scientific Officer en Senior

Mon, December 12, 2011

[ Mon, Dec 12th 2011 ]: Market Wire

Abiomed 2011 Investor Day Webcast Replay Available

[ Mon, Dec 12th 2011 ]: Market Wire

First FDA-Approved Treatment for Myelofibrosis, J .. ssed in Multiple Presentations at 2011 ASH Annual

[ Mon, Dec 12th 2011 ]: Market Wire

Paladin Labs Announces the Canadian Launch of DigiFab(TM) Digoxin Immune Fab (Ovine)

[ Mon, Dec 12th 2011 ]: Market Wire

Celldex Therapeutics Presents Novel Preclinical D .. erican Society of Hematology Meeting in San Diego

[ Mon, Dec 12th 2011 ]: Market Wire

Synageva BioPharma to Present at the 30th Annual .. Morgan Healthcare Conference on January 11, 2012

[ Mon, Dec 12th 2011 ]: Market Wire

Amica Mature Lifestyles to Announce Second Quarte .. Results and Host Conference Call January 16, 2012

[ Mon, Dec 12th 2011 ]: Market Wire

Theravance Announces Initiation of Phase 2 Study .. ARIN Compound, TD-9855, for the Treatment of ADHD

[ Mon, Dec 12th 2011 ]: Market Wire

Lilly Oncology Reveals Findings From Study of JAK2 Inhibitor for Blood Cancers at ASH Meeting

[ Mon, Dec 12th 2011 ]: Market Wire

Community Health Systems Announces Definitive Agreement to Acquire Blue Island, Illinois Hospital

[ Mon, Dec 12th 2011 ]: Market Wire

Health Canada Approves Feraheme (ferumoxytol) to .. ency Anemia in Adults with Chronic Kidney Disease

[ Mon, Dec 12th 2011 ]: Market Wire

AMAG Pharmaceuticals Announces Preliminary Data R .. acy of a Single Infusion of 1020 mg Ferumoxytol (

[ Mon, Dec 12th 2011 ]: Market Wire

Nektar Therapeutics Initiates Phase 3 BEACON Tria .. f NKTR-102 in Women with Metastatic Breast Cancer

[ Mon, Dec 12th 2011 ]: Market Wire

ProMetic Announces Achievement of Significant Targeted Milestone With a Multinational Company

[ Mon, Dec 12th 2011 ]: Market Wire

PDL BioPharma Announces Departure of Chief Financial Officer

[ Mon, Dec 12th 2011 ]: Market Wire

Geron Initiates Phase 2 Trial of GRN1005 in Brain Metastases From Breast Cancer

[ Mon, Dec 12th 2011 ]: Market Wire

Mylan Names John Thievon President of Dey Pharma

[ Mon, Dec 12th 2011 ]: Market Wire

Soligenix Announces Publication of Results of its .. al Trial of orBec in the Prevention of Acute GVHD

[ Mon, Dec 12th 2011 ]: Market Wire

MELA Sciences Announces Additions to Board of Directors

[ Mon, Dec 12th 2011 ]: Market Wire

Emergent BioSolutions to Participate in January 2012 Investor Conferences

[ Mon, Dec 12th 2011 ]: Market Wire

PDL BioPharma Corrects Its Adjusted Conversion Rates for Its Convertible Notes

[ Mon, Dec 12th 2011 ]: Market Wire

Kraig Biocraft Laboratories Receives New Custom Z .. er Configurations for Advanced Fibers Development

[ Mon, Dec 12th 2011 ]: Market Wire

Abbott and Reata Pharmaceuticals Announce Agreeme .. ze Next-Generation Antioxidant Inflammation Modul

[ Mon, Dec 12th 2011 ]: Market Wire

10-Year Study Demonstrates IRIDEX MicroPulsea" La .. ffective for Patients with Diabetic Macular Edema

[ Mon, Dec 12th 2011 ]: Market Wire

Inovio Pharmaceuticals to Present at Oppenheimer Investor Conference

Sun, December 11, 2011

[ Sun, Dec 11th 2011 ]: Market Wire

Pharming granted U.S. patent on C1 inhibitor use in ischemia reperfusion injury indications

[ Sun, Dec 11th 2011 ]: Market Wire

Onyx Pharmaceuticals Announces FDA Standard Revie .. New Drug Application for the Treatment of Relapse

Sat, December 10, 2011

[ Sat, Dec 10th 2011 ]: Market Wire

Onyx Pharmaceuticals Provides Update on Carfilzom .. 3rd American Society of Hematology Annual Meeting

[ Sat, Dec 10th 2011 ]: Market Wire

Brower Piven Encourages Investors Who Have Losses .. nvestment in Pain Therapeutics, Inc. to Inquire A

[ Sat, Dec 10th 2011 ]: Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;

[ Sat, Dec 10th 2011 ]: Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;

[ Sat, Dec 10th 2011 ]: Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;

[ Sat, Dec 10th 2011 ]: Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;; u

[ Sat, Dec 10th 2011 ]: Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;

[ Sat, Dec 10th 2011 ]: Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;

[ Sat, Dec 10th 2011 ]: Market Wire

Abiomed Announces Expanded Heart Recovery Strategy with Multi Year Growth Initiatives

[ Sat, Dec 10th 2011 ]: Market Wire

Exact Sciences Announces Successful Completion of Public Offering of Common Stock

[ Sat, Dec 10th 2011 ]: Market Wire

Gilead maakt tweejaarsgegevens bekend van crucial .. ie van elvitegravir, een integraseremmer voor hiv

[ Sat, Dec 10th 2011 ]: Market Wire

Gilead gibt Zweijahresdaten der Phase-3-Pivotstud .. itegravir, einem Integrasehemmer bei HIV, bekannt

[ Sat, Dec 10th 2011 ]: Market Wire

Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir, un inibitore dell

[ Sat, Dec 10th 2011 ]: Market Wire

Data Shows Medtronic AdaptiveStima" with RestoreSensora" Provides Pain Relief and Convenience

[ Sat, Dec 10th 2011 ]: Market Wire

Gilead Announces Two-Year Data From Pivotal Phase .. y of Elvitegravir, an Integrase Inhibitor for HIV

Fri, December 9, 2011

[ Fri, Dec 09th 2011 ]: Market Wire

Saxena White P.A. Files a Securities Fraud Class Action Against Hospira, Inc.

[ Fri, Dec 09th 2011 ]: Market Wire

Gilead anuncia datos de dos aos del estudio funda .. egravir, un inhibidor de la integrada para el VIH

[ Fri, Dec 09th 2011 ]: Market Wire

Leading Addiction Expert Joins Catasys as Chief Medical Officer

[ Fri, Dec 09th 2011 ]: Market Wire

Kahn Swick & Foti, LLC Announces Investigation in .. Report of Possible Federal Manufacturing Suspens

[ Fri, Dec 09th 2011 ]: Market Wire

HealthSpring, Inc. Announces Record Date and Meet .. of Stockholders in Connection with the Proposed M

[ Fri, Dec 09th 2011 ]: Market Wire

Amgen to Present at the 22nd Annual Oppenheimer Healthcare Conference

[ Fri, Dec 09th 2011 ]: Market Wire

Warnex Sells Its Medical and Forensic Testing Ope .. Reaches Repayment Agreement With Its Debentureho

[ Fri, Dec 09th 2011 ]: Market Wire

Shengtai Pharmaceutical, Inc. Announces Annual Meeting Date

[ Fri, Dec 09th 2011 ]: Market Wire

Abbott Declares 352nd Consecutive Quarterly Dividend

[ Fri, Dec 09th 2011 ]: Market Wire

Thoratec Presentation at Oppenheimer Conference to Be Webcast

[ Fri, Dec 09th 2011 ]: Market Wire

HeartWare to Present at the Oppenheimer 22nd Annual Healthcare Conference

[ Fri, Dec 09th 2011 ]: Market Wire

Quest Diagnostics Care360a" Named Top e-Prescribing Platform by Black Book Rankings

[ Fri, Dec 09th 2011 ]: Market Wire

Lilly for Better Healtha" expande su sitio web pa .. in de salud y herramientas interactivas en espaol

[ Fri, Dec 09th 2011 ]: Market Wire

AVI BioPharma Names Jayant Aphale, Ph.D., Senior Vice President of Technical Operations

Datos finales de la Fase II que evalan REVLIMID y rituximab en pacientes con leucemia linfoctica crnica recurrente o resistente

//health-fitness.news-articles.net/content/2011/ .. a-linfoctica-crnica-recurrente-o-resistente.html

Published in Health and Fitness on Wednesday, December 14th 2011 at 4:47 GMT by Market Wire
^{🞛 This publication is a summary or evaluation of another publication}

BOUDRY, Suiza--([ BUSINESS WIRE ])--Celgene International Srl, filial de Celgene Corporation, (NASDAQ: CELG), ha anunciado los resultados finales de un estudio de investigacin de fase II que evaluaba la combinacin de REVLIMID (lenalidomida) y rituximab en 59 pacientes con leucemia linfoctica crnica recurrente o resistente. Los datos se han presentado en la 53 Reunin Anual de la American Society of Hematology en San Diego (California).

El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.